107 related articles for article (PubMed ID: 15990452)
21. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
22. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of matrix metalloproteinase-9 dependent on hyaluronan synthesis after sciatic nerve injury.
Yong N; Guoping C
Neurosci Lett; 2008 Oct; 444(3):259-63. PubMed ID: 18725268
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy.
Siebert H; Dippel N; Mäder M; Weber F; Brück W
J Neuropathol Exp Neurol; 2001 Jan; 60(1):85-93. PubMed ID: 11202178
[TBL] [Abstract][Full Text] [Related]
25. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
26. Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems.
Hughes PM; Wells GM; Perry VH; Brown MC; Miller KM
Neuroscience; 2002; 113(2):273-87. PubMed ID: 12127085
[TBL] [Abstract][Full Text] [Related]
27. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
[TBL] [Abstract][Full Text] [Related]
28. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
[TBL] [Abstract][Full Text] [Related]
29. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification.
Bailey M; Pillarisetti S; Jones P; Xiao H; Simionescu D; Vyavahare N
Cardiovasc Pathol; 2004; 13(3):146-55. PubMed ID: 15081471
[TBL] [Abstract][Full Text] [Related]
30. Extracellular matrix and matrix metalloproteinases in sciatic nerve.
Platt CI; Krekoski CA; Ward RV; Edwards DR; Gavrilovic J
J Neurosci Res; 2003 Nov; 74(3):417-29. PubMed ID: 14598318
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase-9 and metalloproteinase-2 activity and expression is reduced by melatonin during experimental colitis.
Esposito E; Mazzon E; Riccardi L; Caminiti R; Meli R; Cuzzocrea S
J Pineal Res; 2008 Sep; 45(2):166-73. PubMed ID: 18429971
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-13, and MT1-MMP in skin tumors of human papillomavirus type 8 transgenic mice.
Akgül B; Pfefferle R; Marcuzzi GP; Zigrino P; Krieg T; Pfister H; Mauch C
Exp Dermatol; 2006 Jan; 15(1):35-42. PubMed ID: 16364029
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting effect of minocycline on the regeneration of peripheral nerves.
Keilhoff G; Langnaese K; Wolf G; Fansa H
Dev Neurobiol; 2007 Sep; 67(10):1382-95. PubMed ID: 17638380
[TBL] [Abstract][Full Text] [Related]
34. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis.
Sandya S; Sudhakaran PR
Exp Biol Med (Maywood); 2007 May; 232(5):629-37. PubMed ID: 17463159
[TBL] [Abstract][Full Text] [Related]
35. Characterization of matrix metalloproteinases in denervated muscle.
Demestre M; Orth M; Wells GM; Gearing AJ; Hughes RA; Gregson NA
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):545-55. PubMed ID: 16150125
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells.
Zuo Y; Perkins NM; Tracey DJ; Geczy CL
Pain; 2003 Oct; 105(3):467-479. PubMed ID: 14527707
[TBL] [Abstract][Full Text] [Related]
37. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea.
Heiligenhaus A; Li HF; Yang Y; Wasmuth S; Steuhl KP; Bauer D
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4079-85. PubMed ID: 16249483
[TBL] [Abstract][Full Text] [Related]
38. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
40. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
